Oculomotor measures reveal the temporal dynamics of preparing for search.

Prog Brain Res

Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Institute of Brain and Behavior Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. Electronic address:

Published: July 2018

Theories of visual search assume that selection is driven by an active template representation of the target object. Earlier studies suggest that template activation occurs prior to search, but the temporal dynamics of such preactivation remain unclear. Two experiments employed microsaccades to track both general preparation (i.e., anticipation of the search task as such) and template-specific preparation (i.e., anticipation of target selection) of visual search. Participants memorized a target color (i.e., the template) for an upcoming search task. During the delay period, we presented an irrelevant rapid serial visual presentation (RSVP) of lateralized colored disks. Crucially, at different time points into the RSVP, the template color was inserted, allowing us to measure attentional biases toward the template match as a function of time. Results showed a general suppression of saccades: the closer in time to the search display, the less saccades were produced. This suppression was stronger when a template-matching color was present compared to when absent. However, when microsaccades occurred, they were biased toward the template-matching color and more so just prior to the search display. We conclude that observers adapt search template activation to the anticipated moment of search, and that microsaccades reflect general as well as target-specific preparation effects.

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.pbr.2017.07.003DOI Listing

Publication Analysis

Top Keywords

search
10
temporal dynamics
8
visual search
8
template activation
8
prior search
8
preparation anticipation
8
search task
8
search display
8
template-matching color
8
template
6

Similar Publications

A patent review of xanthine oxidase inhibitors (2021-present).

Expert Opin Ther Pat

December 2024

Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China.

Introduction: Xanthine oxidase (XO) catalyzes the oxidation of both hypoxanthine and xanthine in the last two steps of the purine metabolic pathway, serving as a rate-limiting enzyme for uric acid production as well as a key target for the treatment of gout and other hyperuricemia-related conditions.

Areas Covered: This paper reviews XO inhibitors in patents from 2021 to the present. We summarize in detail the structural classes and characteristics, in vitro and in vivo biological results, and structure‒activity relationships of synthetic inhibitors, as well as the sources, specific structures, research methods, and biological activities of XO inhibitors from natural products.

View Article and Find Full Text PDF

Real-world experience of diagnosis, disability, and daily management in parents of children with different genetic developmental and epileptic encephalopathies: a qualitative study.

Ann Med

December 2025

Research Group of Humanities and Qualitative Research in Health Science of Universidad Rey Juan Carlos (Hum&QRinHS), Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, Alcorcón, Spain.

Purpose: This study describes the experience of parents of children with developmental and epileptic encephalopathies (DEE) and how the disease impacts their daily lives.

Materials And Methods: A descriptive qualitative study was conducted using purposeful sampling. Twenty-one parents of children with DEEs caused by SCN1A, KCNQ2, CDKL5, PCDH19, and GNAO1 variants were included.

View Article and Find Full Text PDF

<i>Ormocarpum trichocarpum</i> (Taub.) Engl. is a shrub or small tree harvested from the wild as a source of food, traditional medicines and wood.

View Article and Find Full Text PDF

The trend of an annual increase in the detection of new cases of osteoarthritis (OA) and an increase in the number of patients with chronic lower back pain (LBP) calls for the search for new drugs and pharmaconutraceuticals with anti-inflammatory and chondroprotective properties. In 2019, approaches to the treatment of pain in OA significantly changed. In international and Russian clinical guidelines (CG), pharmaconutraceutical chondroitin sulfate (CS) and glucosamine sulfate (GS) are recommended for OA of different localization as a basic therapy.

View Article and Find Full Text PDF

Chronic cerebral ischemia (CCI) is one of the most common forms of cerebrovascular disease, which affects a significant number of patients, often leading to disability, cognitive impairment and dementia. The analysis of modern data on the pathogenesis and risk factors for the development of CCI, as well as on the mechanisms of action of Mexidol on various links in the pathogenesis of CCI. A systematic search was conducted in the PubMed, MEDLINE and Google Scholar databases, on Russian and English-language sites with open access publications on the problem of CCI and on the drug Mexidol in the period from 2014 to 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!